Related content

Novel C-Terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents

By Cohen Stephanie   Mukerji Ridhwi   Samadi Abbas   Zhao Huiping   Blagg Brian   Cohen Mark  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 483-490

Springer Publishing Company

Access to resources Recommend Favorite

Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck

By Young M.  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 375-382

Springer Publishing Company

Access to resources Recommend Favorite

Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 45-57

Bentham Science Publishers

Access to resources Recommend Favorite

Retinoic Acid Concentrations in Patients With Squamous Cell Carcinoma of the Head and Neck

By Wahlberg P.   Fex G.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 366-367

Elsevier

Access to resources Recommend Favorite

Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck

By Katori Hideaki   Tsukuda Mamoru   Taguchi Takahide  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 789-794

Springer Publishing Company

Access to resources Recommend Favorite